We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
- Authors
Jaeckle, Kurt A.; Anderson, S. K.; Twohy, Erin L.; Dixon, Jesse G.; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J.; Sarkaria, Jann N.; Brown, Paul D.; Flynn, P. J.; Schwerkoske, John; Buckner, Jan C.; Galanis, Evanthia
- Abstract
The last author's first name was truncated in the initial online publication. The original article has been corrected.
- Subjects
CANCER treatment; THERAPEUTICS; ELECTRONIC publications; PERSONAL names
- Publication
Journal of Neuro-Oncology, 2019, Vol 143, Issue 3, p583
- ISSN
0167-594X
- Publication type
Correction Notice
- DOI
10.1007/s11060-019-03201-3